Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death. / Aladdin, H; Ullum, H; Lepri, A Cozzi; Leffers, H; Katzenstein, T; Gerstoft, J; Gjedde, S B; Phillips, A N; Skinhøj, P; Pedersen, Bente Klarlund.
In: Scandinavian Journal of Immunology, Vol. 50, No. 2, 08.1999, p. 223-7.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death
AU - Aladdin, H
AU - Ullum, H
AU - Lepri, A Cozzi
AU - Leffers, H
AU - Katzenstein, T
AU - Gerstoft, J
AU - Gjedde, S B
AU - Phillips, A N
AU - Skinhøj, P
AU - Pedersen, Bente Klarlund
PY - 1999/8
Y1 - 1999/8
N2 - The ability of cytotoxic T lymphocytes (CTL) to control and influence the outcome of human immunodeficiency virus (HIV) infection is not fully understood. The association between HIV-CTL activity and disease progression was evaluated prospectively in 36 HIV-1-infected individuals with a median follow-up of 3.0 years. HIV-CTL activity was measured in a 4 h Cr* release assay using autologous target cells expressing HIV-1 BRU isolate gene products (gp-120, gag, pol, nef) and a bulk culture of autologous effector cells. The CD4 count was measured at enrolment and plasma HIV RNA was measured retrospectively. The present study failed to support the hypothesis that HIV-CTL activity, as measured using the present method, is important in reducing the risk of death in HIV-infected individuals. However, using other approaches and methods could possibly yield other conclusions, and further prospective studies are needed to examine the relationship between CTL and disease progression.
AB - The ability of cytotoxic T lymphocytes (CTL) to control and influence the outcome of human immunodeficiency virus (HIV) infection is not fully understood. The association between HIV-CTL activity and disease progression was evaluated prospectively in 36 HIV-1-infected individuals with a median follow-up of 3.0 years. HIV-CTL activity was measured in a 4 h Cr* release assay using autologous target cells expressing HIV-1 BRU isolate gene products (gp-120, gag, pol, nef) and a bulk culture of autologous effector cells. The CD4 count was measured at enrolment and plasma HIV RNA was measured retrospectively. The present study failed to support the hypothesis that HIV-CTL activity, as measured using the present method, is important in reducing the risk of death in HIV-infected individuals. However, using other approaches and methods could possibly yield other conclusions, and further prospective studies are needed to examine the relationship between CTL and disease progression.
KW - Adult
KW - CD4 Lymphocyte Count
KW - Cells, Cultured
KW - Disease Progression
KW - Female
KW - Follow-Up Studies
KW - Gene Products, gag
KW - Gene Products, nef
KW - Gene Products, pol
KW - HIV Antigens
KW - HIV Envelope Protein gp120
KW - HIV Infections
KW - HIV-1
KW - Humans
KW - Male
KW - Middle Aged
KW - RNA, Viral
KW - Retrospective Studies
KW - Risk Factors
KW - T-Lymphocytes, Cytotoxic
KW - nef Gene Products, Human Immunodeficiency Virus
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
M3 - Journal article
C2 - 10447929
VL - 50
SP - 223
EP - 227
JO - Scandinavian Journal of Immunology, Supplement
JF - Scandinavian Journal of Immunology, Supplement
SN - 0301-6323
IS - 2
ER -
ID: 180572145